Why the study?
Does homozygosity for LPL haplotype 1 prevent coronary artery disease in Mexican-Americans?
Does homozygosity for LPL haplotype 1 prevent coronary artery disease in Mexican-Americans?
Homozygosity for LPL haplotype 1 is associated with a 50% reduced odds of coronary artery disease in Mexican-Americans, highlighting the importance of ethnic-specific genetic risk profiling.
Should not yet inform clinical decisions; leaves open prospective validation of LPL haplotype 1 in Mexican-Americans.
PURPOSE: To illustrate an approach of deriving haplotypes for genetic association studies, using the lipoprotein lipase (LPL) gene and coronary artery disease. METHODS: Six polymorphisms sufficient to distinguish the most common haplotypes in the 3' end of LPL were identified by genotyping 10 polymorphisms in a small pilot population. These were used to haplotype LPL in large family samples of Mexican-Americans and non-Hispanic Caucasians. A case-control association study was performed comparing Mexican-Americans with and without coronary artery disease. RESULTS: The two ethnic groups exhibited significant genetic differences. Among Mexican-Americans, homozygosity for LPL haplotype 1 was protective against coronary artery disease (OR = 0.50, 95% CI 0.27-0.91). CONCLUSION: This study outlines the haplotype structure of the LPL gene, illustrates the utility of haplotype-based analysis in association studies, and demonstrates the importance of defining haplotype frequencies for different ethnic groups.
No takes yet. Share an insight, caveat, or question.
Goodarzi et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: